Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: A meta-analysis of epidemiologic studies

Luigino Dal Maso, Silvia Franceschi

Research output: Contribution to journalArticle

194 Citations (Scopus)

Abstract

The present meta-analysis was conducted to evaluate the strength and the consistency of the association between hepatitis C virus (HCV) infection and non-Hodgkin lymphoma (NHL) and other lymphoid neoplasms. Only studies with ≥100 cases which were also adjusted for sex and age were included. Fifteen case-control studies and three prospective studies contributed to present analysis, nine of which had not been included in previous meta-analyses. We calculated the pooled relative risks (RR) with corresponding 95% confidence intervals (95% CI), as a weighted average of the estimated RRs by random-effect models. The pooled RR of all NHL among HCV-positive individuals was 2.5 (95% CI, 2.1-3.0), but substantial heterogeneity was found between studies and by study design. Pooled RRs were 2.5 (95% CI, 2.1-3.1) in case-control studies and 2.0 (95% CI, 1.8-2.2) in cohort ones. The strongest source of heterogeneity seemed to be the prevalence of HCV among NHL-free study subjects (RR for NHL among HCV-positive individuals 3.0 and 1.9, respectively, for ≥5% and

Original languageEnglish
Pages (from-to)2078-2085
Number of pages8
JournalCancer Epidemiology Biomarkers and Prevention
Volume15
Issue number11
DOIs
Publication statusPublished - Nov 2006

Fingerprint

Hepacivirus
Non-Hodgkin's Lymphoma
Meta-Analysis
Epidemiologic Studies
Lymphoma
Confidence Intervals
Case-Control Studies
Neoplasms
Virus Diseases
Prospective Studies

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Cite this

Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms : A meta-analysis of epidemiologic studies. / Dal Maso, Luigino; Franceschi, Silvia.

In: Cancer Epidemiology Biomarkers and Prevention, Vol. 15, No. 11, 11.2006, p. 2078-2085.

Research output: Contribution to journalArticle

@article{8eb8ba0546e1451ca034720b3229bfb3,
title = "Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: A meta-analysis of epidemiologic studies",
abstract = "The present meta-analysis was conducted to evaluate the strength and the consistency of the association between hepatitis C virus (HCV) infection and non-Hodgkin lymphoma (NHL) and other lymphoid neoplasms. Only studies with ≥100 cases which were also adjusted for sex and age were included. Fifteen case-control studies and three prospective studies contributed to present analysis, nine of which had not been included in previous meta-analyses. We calculated the pooled relative risks (RR) with corresponding 95{\%} confidence intervals (95{\%} CI), as a weighted average of the estimated RRs by random-effect models. The pooled RR of all NHL among HCV-positive individuals was 2.5 (95{\%} CI, 2.1-3.0), but substantial heterogeneity was found between studies and by study design. Pooled RRs were 2.5 (95{\%} CI, 2.1-3.1) in case-control studies and 2.0 (95{\%} CI, 1.8-2.2) in cohort ones. The strongest source of heterogeneity seemed to be the prevalence of HCV among NHL-free study subjects (RR for NHL among HCV-positive individuals 3.0 and 1.9, respectively, for ≥5{\%} and",
author = "{Dal Maso}, Luigino and Silvia Franceschi",
year = "2006",
month = "11",
doi = "10.1158/1055-9965.EPI-06-0308",
language = "English",
volume = "15",
pages = "2078--2085",
journal = "Cancer Epidemiology Biomarkers and Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "11",

}

TY - JOUR

T1 - Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms

T2 - A meta-analysis of epidemiologic studies

AU - Dal Maso, Luigino

AU - Franceschi, Silvia

PY - 2006/11

Y1 - 2006/11

N2 - The present meta-analysis was conducted to evaluate the strength and the consistency of the association between hepatitis C virus (HCV) infection and non-Hodgkin lymphoma (NHL) and other lymphoid neoplasms. Only studies with ≥100 cases which were also adjusted for sex and age were included. Fifteen case-control studies and three prospective studies contributed to present analysis, nine of which had not been included in previous meta-analyses. We calculated the pooled relative risks (RR) with corresponding 95% confidence intervals (95% CI), as a weighted average of the estimated RRs by random-effect models. The pooled RR of all NHL among HCV-positive individuals was 2.5 (95% CI, 2.1-3.0), but substantial heterogeneity was found between studies and by study design. Pooled RRs were 2.5 (95% CI, 2.1-3.1) in case-control studies and 2.0 (95% CI, 1.8-2.2) in cohort ones. The strongest source of heterogeneity seemed to be the prevalence of HCV among NHL-free study subjects (RR for NHL among HCV-positive individuals 3.0 and 1.9, respectively, for ≥5% and

AB - The present meta-analysis was conducted to evaluate the strength and the consistency of the association between hepatitis C virus (HCV) infection and non-Hodgkin lymphoma (NHL) and other lymphoid neoplasms. Only studies with ≥100 cases which were also adjusted for sex and age were included. Fifteen case-control studies and three prospective studies contributed to present analysis, nine of which had not been included in previous meta-analyses. We calculated the pooled relative risks (RR) with corresponding 95% confidence intervals (95% CI), as a weighted average of the estimated RRs by random-effect models. The pooled RR of all NHL among HCV-positive individuals was 2.5 (95% CI, 2.1-3.0), but substantial heterogeneity was found between studies and by study design. Pooled RRs were 2.5 (95% CI, 2.1-3.1) in case-control studies and 2.0 (95% CI, 1.8-2.2) in cohort ones. The strongest source of heterogeneity seemed to be the prevalence of HCV among NHL-free study subjects (RR for NHL among HCV-positive individuals 3.0 and 1.9, respectively, for ≥5% and

UR - http://www.scopus.com/inward/record.url?scp=33845315247&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845315247&partnerID=8YFLogxK

U2 - 10.1158/1055-9965.EPI-06-0308

DO - 10.1158/1055-9965.EPI-06-0308

M3 - Article

C2 - 17119031

AN - SCOPUS:33845315247

VL - 15

SP - 2078

EP - 2085

JO - Cancer Epidemiology Biomarkers and Prevention

JF - Cancer Epidemiology Biomarkers and Prevention

SN - 1055-9965

IS - 11

ER -